{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:19:00Z","timestamp":1787797140629,"version":"build-2784847793"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vaccine.2026.129002","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:46:44Z","timestamp":1786070804000},"page":"129002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomarkers usefulness have a time frame to be respected"],"prefix":"10.1016","volume":"90","author":[{"given":"Alessandro","family":"Capucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129002_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128535","article-title":"Transient elevation on NT-pro BNP after mRNA COVID-19 vaccination in healty adults: a longitudinal biomarker analysis","volume":"80","author":"Dlouhy","year":"2026","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129002_bb0010","article-title":"Serial, repeated, or single measurements of natriuretic peptides (BNP or NT-proBNP) in estimating cardiovascular risk: is it the \u201cimportance of change over time\u201d or the past is good, but the present is better, or both, in clinical context?","volume":"11","author":"Miler","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.vaccine.2026.129002_bb0015","series-title":"ESC Guidelines of the European Society of Cardiology","article-title":"Acute Coronary Syndrome","author":"ESC","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129002_bb0020","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.radcr.2021.07.082","article-title":"Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection","volume":"16","author":"Patrignani","year":"2021","journal-title":"Radiology Case Reports"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129002_bb0025","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/ejhf.2978","article-title":"Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination","volume":"25","author":"Buergin","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129002_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129002_bb0035","article-title":"Inflammatory and cardiac biomarkers in relation to post-acute COVID-19 and mortality: what we know after successive pandemic waves","volume":"12","author":"Lionte","year":"2022","journal-title":"Diagnostics (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600811X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600811X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:09:28Z","timestamp":1787796568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600811X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":7,"alternative-id":["S0264410X2600811X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers usefulness have a time frame to be respected","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129002"}}